Dr. Leota Faleolo Tafuna'i

Dr. Leota Faleolo Tafuna'i is a consultant endocrinologist at Tupua Tamasese Meaole Hospital in Apia, Samoa, specialising in type 2 diabetes, obesity medicine, and thyroid disease. With 11 years of clinical experience, FRACP qualifications, and a postgraduate diploma in diabetes management from the University of Otago, she is exceptionally well-equipped to address Samoa's severe NCD burden. Samoa and other Pacific Island nations face among the world's highest rates of type 2 diabetes and obesity, driven by dietary transitions and genetic susceptibility. Dr. Tafuna'i's specialist endocrine skills are of profound importance for the Samoan population, and her training in New Zealand and Australia provides internationally benchmarked expertise delivered within a Pacific Island cultural context.

Dr. Tafuna'i completed her MBBS at the Fiji School of Medicine, followed by specialist physician training leading to the FRACP (Fellowship of the Royal Australasian College of Physicians — Endocrinology and Metabolism), one of the most demanding specialist medical qualifications in the Australasian region. She additionally obtained a Postgraduate Diploma in Diabetes Management from the University of Otago, New Zealand, providing structured academic training in diabetes clinical management, education, and technology. Her training encompassed insulin pump therapy, continuous glucose monitoring, and diabetic complication assessment. She participates in RACP and New Zealand Endocrine Society CME.

Dr. Tafuna'i's endocrine practice is centred on the management of type 2 diabetes and metabolic disease in a Pacific Island population context. She manages complex type 2 diabetes using structured insulin regimens, GLP-1 receptor agonists, and SGLT-2 inhibitors, with particular attention to renal function in a population with high rates of diabetic nephropathy. Her obesity medicine expertise addresses bariatric pharmacotherapy and pre-bariatric surgery assessment in collaboration with surgical teams. Her thyroid practice covers hypothyroidism, hyperthyroidism, goitre, and thyroid nodule assessment. She also manages metabolic syndrome and provides education-focused diabetes programmes tailored to Samoan cultural values and dietary patterns.

Tupua Tamasese Meaole Hospital is the national referral hospital for Samoa and the primary site for specialist endocrine care in the country. Dr. Tafuna'i serves both local Samoan patients and the expatriate and international visitor population in Apia. She consults in Samoan and English. International patients — particularly from the Samoan diaspora in New Zealand and Australia who return home — can access specialist diabetes and endocrine management through her clinic. Faleolo International Airport connects directly to Auckland and Sydney, supporting medical travel for complex cases requiring Australasian tertiary input.

Dr. Tafuna'i has been recognised by the Samoan Ministry of Health and Pacific endocrinology networks for her contributions to diabetes and metabolic disease management in Samoa. Her FRACP qualification reflects the highest level of specialist physician training in Australasia. She has been commended for her culturally adapted diabetes education programmes and for pioneering the use of advanced diabetes technologies in the Samoan hospital setting. She has presented at Pacific health conferences on addressing the NCD epidemic in Samoa and contributed to PAHO and WHO Pacific obesity strategy consultations.